强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JNJ 强生

交易中 07-22 13:19:40 EDT

154.36

-0.33

-0.22%

最高155.09	最低153.59	成交量220.63万
今开154.77	昨收154.69	日振幅0.97%
总市值3,715亿	流通市值3,708亿	总股本24.07亿
成交额3.41亿	换手率0.09%	流通股本24.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":154.355,"timestamp":1721668779632,"preClose":154.69,"halted":0,"volume":2206342,"delay":0,"floatShares":2402302636,"shares":2406679183,"eps":15.450808,"marketStatus":"交易中","marketStatusCode":2,"change":-0.335,"latestTime":"07-22 13:19:40 EDT","open":154.77,"high":155.09,"low":153.59,"amount":340508666.08534,"amplitude":0.009697,"askPrice":154.4,"askSize":100,"bidPrice":154.36,"bidSize":200,"shortable":3,"etf":0,"ttmEps":15.450808,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":-797371200000,"adjPreClose":154.69,"adrRate":0,"dividendRate":0.031162,"preHourTrading":{"tag":"盘前","latestPrice":154.735,"preClose":154.69,"latestTime":"09:29 EDT","volume":15221,"amount":2352822.9098199997,"timestamp":1721654999610},"postHourTrading":{"tag":"盘后","latestPrice":154.69,"preClose":154.69,"latestTime":"19:59 EDT","volume":891709,"amount":137938238.321993,"timestamp":1721433592785},"volumeRatio":0.41992,"impliedVol":0.191,"impliedVolPercentile":0.5339},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"2453755009","title":"强生的ADC版图：前列腺癌能否成为突破口？","url":"https://stock-news.laohu8.com/highlight/detail?id=2453755009","media":"药智网","labels":["Company Corporation","Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2453755009?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:06","pubTimestamp":1721635563,"startTime":"0","endTime":"0","summary":"2024年，强生又与ADC生物技术公司Ambrx Biopharma达成收购协议，20亿美元囊获多款临床阶段ADC药物。本次交易，强生看中的是Mersana的二代ADC平台Dolasynthen。目前，强生与多禧生物合作的ADC项目尚未公布研究进展。前列腺癌潜力ADC：ARX517世界癌症研究基金会的数据显示，前列腺癌是全球男性第二大常见的癌症。这个阶段的前列腺癌患者，标准治疗中的放化疗、激素治疗往往可能失效，亟需找到新的有效治疗。Ambrx表示，强生将加速ARX517治疗晚期前列腺癌的I/II期APEX-01研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216173195e79bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216173195e79bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation,Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1196500208.SGD","LU2602419157.SGD","LU0466842654.USD","LU0889566641.SGD","LU1162221912.USD","ADC","LU0122379950.USD","LU1066053197.SGD","LU1430594728.SGD","BK4588","LU1032466523.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0882574055.USD","LU1221951046.USD","LU0234572021.USD","LU1244550221.USD","IE00BSNM7G36.USD","LU1032955483.USD","LU1506573853.SGD","LU2347655156.SGD","BK4568","LU0640476718.USD","LU1732799900.SGD","LU0795875169.SGD","BK4550","IE00B19Z3581.USD","LU0795875086.SGD","LU1059921491.USD","LU1074936037.SGD","BK4504","SG9999001440.SGD","BK4231","JNJ","LU0345770308.USD","LU1935042991.SGD","BK4585","SG9999002224.SGD","LU2133065610.SGD","BK4592","LU1929549753.HKD","BK4559","LU1066051225.USD","LU1066051498.USD","LU1244550494.USD","BK4581","LU1221951129.SGD","IE000M9KFDE8.USD","LU0345770993.USD","BK4007"],"gpt_icon":1},{"id":"2452123264","title":"肿瘤市场大洗牌，谁是新王","url":"https://stock-news.laohu8.com/highlight/detail?id=2452123264","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452123264?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:36","pubTimestamp":1721371003,"startTime":"0","endTime":"0","summary":"根据Evaluate发布最新报告，2030年全球药企的总销售额将超过1.7万亿美元。当然，尽管如此，肿瘤仍然是最有价值、最吸金的治疗领域，预计2030年所有产品的销售额将超过3700亿美元。巨大的市场，纷争自然不止。Evaluate预计，2030年强生将在达雷妥尤单抗的大力支持，成为肿瘤领域第一，紧随其后的是阿斯利康、默沙东、罗氏和第一三共。无论Evaluate预测中下一个肿瘤霸主强生还是昔日霸主罗氏，都是靠血液瘤重磅炸弹为基础，一步步奠定自己的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/235396","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0345770993.USD","LU2133065610.SGD","SG9999002224.SGD","LU1162221912.USD","IE00B2B36J28.USD","LU1221951046.USD","IE00B4R5TH58.HKD","LU1941712348.USD","LU0234572021.USD","JNJ","BK4504","LU0965508806.USD","LU1037948897.HKD","LU2347655156.SGD","BK4592","LU1934455194.USD","LU1974910355.USD","LU0889566641.SGD","LU2602419157.SGD","LU1244550494.USD","LU0345770308.USD","LU1941712264.USD","LU0238689110.USD","LU0795875086.SGD","BK4588","BK4581","LU1032466523.USD","LU1430594728.SGD","LU0965509010.AUD","LU1059921491.USD","IE00BN8TJ469.HKD","MRK","LU1934455277.USD","LU1929549753.HKD","LU0965509101.SGD","LU0266013472.USD","FL","IE00B19Z3581.USD","LU1221951129.SGD","LU1291159041.SGD","LU1196500208.SGD","LU0640476718.USD","LU1032955483.USD","LU0320765489.SGD","LU0265550946.USD","LU0985320562.USD","LU0070302665.USD","LU1116320901.HKD","IE00BSNM7G36.USD","LU0861579265.USD"],"gpt_icon":0},{"id":"2452100252","title":"BUZZ-券商观点：强生公司在法律挑战中实现增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2452100252","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452100252?lang=zh_cn&edition=full","pubTime":"2024-07-18 19:59","pubTimestamp":1721303945,"startTime":"0","endTime":"0","summary":"** 25 家券商的平均推荐值为 \"买入\"，中位预测值为 170 美元--LSEG 数据尽管面临法律挑战，但对销售目标和产品上市充满信心** RBC 认为，结合 JNJ 现有的产品组合、新产品的推出以及产品线的能见度，该公司到 2025 年实现 570 亿美元 销售目标的信心大增。** 花旗集团 预计该公司高端 TECNIS Odyssey IOL 镜片的商业化推出将加快下半年的收入增长。** 瑞银集团 对JNJ在 2024 年实现约 6% 医疗技术增长指导的能力仍充满信心，这主要得益于扩大对高增长终端市场的投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU2347655156.SGD","LU0889566641.SGD","LU0320765646.SGD","LU1267930813.SGD","LU1221951046.USD","IE00B1BXHZ80.USD","BK4532","IE00B7SZLL34.SGD","BK4585","LU1066051811.HKD","LU1162221912.USD","LU1244550494.USD","SG9999001440.SGD","LU1929549753.HKD","LU1261432733.SGD","LU1032466523.USD","LU2468319806.SGD","LU0234572021.USD","LU0466842654.USD","LU1244550577.SGD","LU0345770993.USD","LU2602419157.SGD","BUZZ","LU1023059063.AUD","BK4588","LU0795875086.SGD","BK4568","IE00B19Z3581.USD","LU0912757837.SGD","LU1059921491.USD","LU1057294990.SGD","LU1732800096.USD","IE0034235303.USD","BK4504","IE00BSNM7G36.USD","LU0345770308.USD","LU1935042991.SGD","LU2133065610.SGD","JNJ","IE0002270589.USD","LU1196500208.SGD","LU0640476718.USD","LU1032955483.USD","BK4581","LU1221951129.SGD","SG9999002224.SGD","LU0792757196.USD","LU1585245621.USD","LU1430594728.SGD"],"gpt_icon":1},{"id":"2452780104","title":"大摩：维持Johnson & Johnson(JNJ.US)评级，由持股观望调整至持股观望评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2452780104","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452780104?lang=zh_cn&edition=full","pubTime":"2024-07-18 18:41","pubTimestamp":1721299272,"startTime":"0","endTime":"0","summary":"大摩：维持Johnson & Johnson(JNJ.US)评级，由持股观望调整至持股观望评级，目标价由167.00美元调整至169.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071818572895d53764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071818572895d53764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JNJ"],"gpt_icon":0},{"id":"2452178977","title":"美国研究综述-Elevance Health、J&J、Primerica","url":"https://stock-news.laohu8.com/highlight/detail?id=2452178977","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452178977?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:06","pubTimestamp":1721286409,"startTime":"0","endTime":"0","summary":"    路透7月18日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Elevance Health、J&J 和 Primerica。要闻             * Elevance Health Inc   ：Leerink Partners将目标价从630美元下调至620美元              * J&J   ：TD Cowen将目标价从195美元下调至185美元              * Primerica Inc   ：杰富瑞将目标价从239美元上调至249美元              * Travelers Companies Inc   ：汇丰银行将目标价从225美元上调至227美元              * UnitedHealth Group Inc   ：汇丰银行将目标价从580美元上调至610美元  以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MET","QCOM","BK4534","ALL","LU0109391861.USD","LU0823414478.USD","VFC","WAFD","BK4532","ALB","FULT","BK4533","VOYA","DKNG","BFC","IE0002270589.USD","ELV","SYF","LCII","IE00B1BXHZ80.USD","PFG","THO","WGO","LC","JNJ","LU0868494617.USD","SG9999001424.SGD","CFG","FCX","LU0289739699.SGD","OPK","BK4107","BK4548","PNFP","TRV","BK4554","PRI","UNH","LESL","LU2468319806.SGD","ALLY","GSBC","BK4166","EQBK","IE00BFSS8Q28.SGD","BK4109","FHN","IE00B894F039.SGD","BHF","LU0211326755.USD"],"gpt_icon":0},{"id":"2452016742","title":"BUZZ-第二季度业绩超出预期，J&J 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2452016742","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452016742?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:04","pubTimestamp":1721235867,"startTime":"0","endTime":"0","summary":" (更新)    7月17日 - ** 药品和设备制造商J&J  股价上涨3.9%，至156.81美元** 受抗癌药物Darzalex和银屑病药物Stelara销售强劲的推动，J&J公司第二季度利润和收入超出预期。** 调整后，公司每股收益为 2.82 美元，预计为 2.70 美元 - LSEG** 畅销药Stelara的销售额增长了3.1%，达到28.9亿美元，高于预期的27.7亿美元。** 目前，J&J预计2024年的总销售额在892亿至896亿美元之间，而之前的预测为887亿至891亿美元。** 包括盘中走势在内，今年以来股价基本持平","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","LU1221951046.USD","LU1162221912.USD","LU1430594728.SGD","LU1506573853.SGD","LU0345770993.USD","BK4007","BK4559","LU0792757196.USD","LU1059921491.USD","IE00B7SZLL34.SGD","BK4568","LU1023059063.AUD","LU2347655156.SGD","LU1032955483.USD","LU0889566641.SGD","LU1935042991.SGD","LU1196500208.SGD","LU1244550577.SGD","BUZZ","LU0345770308.USD","BK4592","BK4581","LU1066053197.SGD","IE00BSNM7G36.USD","LU1244550494.USD","JNJ","LU0795875169.SGD","LU1929549753.HKD","SG9999001440.SGD","LU1585245621.USD","SG9999002224.SGD","BK4550","LU0234572021.USD","BK4588","LU1267930813.SGD","LU0114720955.EUR","LU1032466523.USD","LU0640476718.USD","LU1221951129.SGD","LU2602419157.SGD","LU2133065610.SGD","LU0795875086.SGD","BK4504","LU1244550221.USD","LU1074936037.SGD","LU0466842654.USD","BK4585","LU0912757837.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2452160344","title":"强生2024财年第一财季实现净利润32.55亿美元，同比增加4886.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452160344","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452160344?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:02","pubTimestamp":1721235759,"startTime":"0","endTime":"0","summary":"7月18日，强生公布财报，公告显示公司2024财年第一财季净利润为32.55亿美元，同比增加4886.76%；其中营业收入为213.82亿美元，同比减少13.55%，每股基本收益为1.35美元。从资产负债表来看，强生总负债1,019.46亿美元，其中短期债务85.50亿美元，资产负债比为1.00，流动比率为1.17。机构评级：截至2024年7月18日，当前有20家机构对强生目标价做出预测，其中目标均价为171.52美元，其中最低目标价为155.00美元，最高目标价为215.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071801024295cfcaeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071801024295cfcaeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JNJ"],"gpt_icon":1},{"id":"2452626501","title":"BUZZ-J&J 财报公布后，部分医疗设备制造商股价上涨，其他制造商股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2452626501","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452626501?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:34","pubTimestamp":1721234088,"startTime":"0","endTime":"0","summary":"    7月17日 - ** 强生  发布财报后，部分医疗设备制造商上涨，其他制造商下跌** Zimmer Biomet   上涨2.9%，报110.58美元；美敦力  上涨2.45%，报80.01美元；雅培  上涨2.10%，报104.90美元；史赛克  上涨1.04%，报336.90美元。** 骨科部门的业绩良好，足以影响其他制造商，尤其是在膝关节领域。** 对强劲手术需求的评论为 ZBH 和 SYK 提供了支持--券商 BTIG**J&J在骨科领域的销售额达到 23.1 亿美元。** 今年以来，BSX 上升 ~33%，ISRG 上升 26%，SYK 上升 12.3%，ZBH 下降 ~9%，MDT 下降 ~3%，ABT 下降 ~4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BSX","JNJ","SYK","ISRG","ZBH","ABT","MDT"],"gpt_icon":1},{"id":"2452579201","title":"美股异动 | 强生涨超1.9% Q2销售额及调整后每股收益超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2452579201","media":"港股那点事","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452579201?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:43","pubTimestamp":1721223780,"startTime":"0","endTime":"0","summary":"格隆汇7月17日｜强生(JNJ.US)涨超1.9%，报153.9美元。消息面上，强生第二季度销售额224.5亿美元，同比增长4.3%，市场预估223.2亿美元；调整后每股收益2.82美元，上年同期为2.56美元，市场预估2.70美元。该公司仍然预测全年销售额在880亿至884亿美元之间。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-07-17/doc-incenewu9478713.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-07-17/doc-incenewu9478713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1280957306.USD","IE0002270589.USD","LU0912757837.SGD","BK4568","BK4533","LU0320765646.SGD","BK4592","LU0466842654.USD","BK4559","LU1221951046.USD","LU2602419157.SGD","BK4534","LU0889566641.SGD","LU1066051811.HKD","LU0114720955.EUR","BK4588","LU1732799900.SGD","LU0792757196.USD","IE00B19Z3B42.SGD","LU1244550221.USD","BK4550","LU1066051225.USD","LU1506573853.SGD","LU1244550577.SGD","BK4007","LU2468319806.SGD","JNJ","LU1057294990.SGD","LU0234572021.USD","BK4585","LU0122379950.USD","LU1935042991.SGD","LU1066051498.USD","LU1732800096.USD","SG9999002224.SGD","IE0034235303.USD","BK4532","LU1023059063.AUD","LU1585245621.USD","LU1066053197.SGD","LU1074936037.SGD","LU1261432733.SGD","LU1221951129.SGD","LU0795875169.SGD","IE000M9KFDE8.USD","LU0882574055.USD","LU1267930813.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","LU2347655156.SGD"],"gpt_icon":1},{"id":"2452156076","title":"Johnson & Johnson(JNJ.US)：2024年Q2财报实现营收224.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452156076","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452156076?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:24","pubTimestamp":1721219049,"startTime":"0","endTime":"0","summary":"Johnson & Johnson(JNJ.US)：2024年Q2财报实现营收224.47亿美元，前值为215.19亿美元，预期值为223.1亿美元；每股收益为2.82美元，前值为2.56美元，预期值为2.70美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071720371695cea2db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071720371695cea2db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JNJ"],"gpt_icon":0},{"id":"2452588301","title":"并购成本过高 强生(JNJ.US)下调全年利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2452588301","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452588301?lang=zh_cn&edition=full","pubTime":"2024-07-17 19:25","pubTimestamp":1721215500,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月17日（周三）美股盘前，强生公布了2024年第二季度业绩。强生表示，考虑最近一系列收购产生的成本，下调了全年利润预测。强生希望其抗癌和自身免疫性疾病药物能够弥补 Stelara 即将出现的下滑。并购成本导致利润下滑强生表示，在斥资 131 亿美元收购设备公司 Shockwave Medical 后，其 2024 年的营业销售额将达到 894 亿美元，较上年增长 6.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","LU0889566641.SGD","LU1221951129.SGD","LU1074936037.SGD","LU0114720955.EUR","BK4504","LU1196500208.SGD","IE000M9KFDE8.USD","BK4585","IE00B19Z3581.USD","LU1244550221.USD","LU1066051811.HKD","LU0466842654.USD","BK4007","LU1506573853.SGD","LU1732799900.SGD","JNJ","LU1280957306.USD","LU1066051498.USD","LU1066053197.SGD","LU1059921491.USD","LU0640476718.USD","BK4533","LU0912757837.SGD","LU0122379950.USD","LU1732800096.USD","LU0795875086.SGD","LU2602419157.SGD","SG9999002224.SGD","IE0002270589.USD","LU1023059063.AUD","LU1585245621.USD","LU0882574055.USD","LU1267930813.SGD","LU1221951046.USD","SG9999001440.SGD","LU2347655156.SGD","LU0345770308.USD","IE0034235303.USD","LU1929549753.HKD","BK4581","LU1261432733.SGD","LU1935042991.SGD","BK4550","BK4532","BK4568","IE00B7SZLL34.SGD","LU0234572021.USD","LU2133065610.SGD","LU1162221912.USD"],"gpt_icon":0},{"id":"2452137383","title":"强生(JNJ)二季度净利润达468.6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452137383","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452137383?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:48","pubTimestamp":1721213321,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生(JNJ)第二季度净利润达468.6亿美元；强生第二季度每股收益2.82美元，超过IBES估计的2.7美元；强生二季度总销售额为224.5亿美元，超过IBES估计的223.1亿美元。据悉，强生全球肿瘤药品销售额在第二季度增长了16%至50.9亿美元，其中多发性骨髓瘤药物Darzalex和前列腺癌药物Erleada的销售量居前。强生的肿瘤药品销售一直以来都保持着两位数的增长率。公司希望继续保持肿瘤药品销售的迅猛增长。它正在研发新的治疗肺癌和膀胱癌的药物，在临床试验中显示出了极大的潜力。如果获得监管批准，这些药品将在未来几年内面市并进一步提振肿瘤药品的销售额。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NDVkZDg2NDc3Yzg4NWU0YjQ4Yzk2NjM0NjA5MjYwMQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NDVkZDg2NDc3Yzg4NWU0YjQ4Yzk2NjM0NjA5MjYwMQ==.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2452134696","title":"强生：第二季度销售额224.47亿美元，同比增长4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452134696","media":"企查查","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452134696?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:34","pubTimestamp":1721212472,"startTime":"0","endTime":"0","summary":"7月17日，强生公司公布财报，第二季度销售额224.47亿美元，同比增长4.3%；调整后净利润68.40亿美元，同比增长1.6%；调整后每股收益2.82美元，同比增长10.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071718343995ce1659&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071718343995ce1659&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1221951046.USD","LU1430594728.SGD","LU1506573853.SGD","LU0122379950.USD","BK4007","BK4559","LU0792757196.USD","LU1059921491.USD","LU1280957306.USD","IE00B7SZLL34.SGD","BK4568","LU1023059063.AUD","IE00B1BXHZ80.USD","LU1032955483.USD","LU1732799900.SGD","IE0034235303.USD","LU0889566641.SGD","LU1066051225.USD","LU1935042991.SGD","LU1244550577.SGD","LU0345770308.USD","BK4592","BK4581","LU0320765646.SGD","IE0002270589.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1261432733.SGD","LU1929549753.HKD","SG9999001440.SGD","SG9999002224.SGD","LU0234572021.USD","BK4588","LU0466842654.USD","LU1267930813.SGD","LU0114720955.EUR","LU0882574055.USD","LU1032466523.USD","LU1221951129.SGD","LU2468319806.SGD","BK4532","BK4534","BK4504","LU0795875086.SGD","LU1066051498.USD","LU1074936037.SGD","JNJ","BK4585","IE00B19Z3B42.SGD","LU0912757837.SGD"],"gpt_icon":0},{"id":"1144387901","title":"强生Q2销售额224.5亿美元超预期，下调全年调整后EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=1144387901","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1144387901?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:21","pubTimestamp":1721211674,"startTime":"0","endTime":"0","summary":"预计全年调整后每股收益9.97至10.07美元。","market":"us","thumbnail":"https://static.tigerbbs.com/3a69736e2f37d2d662b6cc8053ba9de2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3a69736e2f37d2d662b6cc8053ba9de2"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"强生Q2销售额224.5亿美元超预期，下调全年调整后EPS","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2452413180","title":"药品销售强劲，J&J业绩超出华尔街预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2452413180","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452413180?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:20","pubTimestamp":1721211618,"startTime":"0","endTime":"0","summary":"根据 LSEG 的数据，该公司第二季度的收入为 224 亿美元，超过了一致 预期的 223 亿美元。根据 LSEG 的数据，Stelara 的销售额增长了 3.1%，达到 28.9 亿美元，高于分析师预期的 27.7 亿美元。分析师说，Darzalex 是 2015 年推出的一种血癌疗法，预计今年将为 J&J 带来超过 110 亿美元的销售额。尽管与 去年同期相比 下降了8.5%，但J&J公司的抗癌药物Imbruvica的销售额  达到了 7.7亿美元，超过了分析师预计的7.18亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU1066051225.USD","LU1244550494.USD","BK4559","BK4532","IE0034235303.USD","LU2602419157.SGD","LU2133065610.SGD","BK4588","BK4534","LU1032466523.USD","BK4550","LU0122379950.USD","LU1066051498.USD","LU1059921491.USD","LU0345770993.USD","LU1244550221.USD","LU0114720955.EUR","LU0795875169.SGD","LU1032955483.USD","LU1430594728.SGD","SG9999002224.SGD","BK4581","LU1221951129.SGD","LU1196500208.SGD","JNJ","LU1506573853.SGD","LU1280957306.USD","LU1162221912.USD","LU0795875086.SGD","LU0882574055.USD","LU1732799900.SGD","LU1935042991.SGD","LU1221951046.USD","LU1066051811.HKD","BK4568","LU0889566641.SGD","LU0466842654.USD","IE00B19Z3581.USD","BK4007","LU0320765646.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1074936037.SGD","BK4585","BK4592","IE00B1BXHZ80.USD","IE00B19Z3B42.SGD","LU0640476718.USD","BK4533"],"gpt_icon":0},{"id":"2452457049","title":"BUZZ--美国股票走势-PNC Financial、美国住宅建筑商、强生公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2452457049","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452457049?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:14","pubTimestamp":1721153654,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      7月16日 - 周二，对利率敏感的小型股领涨华尔街，此前零售销售数据几乎没有打消9月降息的希望，而联合健康的业绩将道指推升至历史新高。美东时间13:56，道琼斯工业平均指数  上涨1.56%，报40,838.49点。标普500指数  上涨0.35%，报5650.98点；纳斯达克综合指数  下跌0.16%，报18443.911点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","MTCH","DDM","AMZN","DXD","KBR","STT","DLTR","MCD","QID","PSQ",".IXIC","LGIH","DDOG","IE00BJLML261.HKD","NQmain","JNJ","BAC","JKS","DJX","LULU",".DJI","TBLA","TSLA","MNQmain","NKE","SHOP","UNH","SCHW",".SPX","NEM","PLTR","SDOW","PNC","YUM","PGR","SQQQ","TQQQ","QLD","SBUX","UDOW","MHO","EPAM","PHM","BA","DOG","UAA","CCS"],"gpt_icon":1},{"id":"2452691209","title":"BUZZ-预览：强生公司在第二季度财报发布前上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2452691209","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452691209?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:16","pubTimestamp":1721146591,"startTime":"0","endTime":"0","summary":"    7月16日 - ** 强生  股价周二上涨0.6%至150.17美元，将于周三开盘前发布第二季度财报。** LSEG数据显示，华尔街分析师预计强生第二季度营收为223亿美元，比去年同期下降13%；每股收益为2.70美元，去年同期为2.80美元。** 在过去 8 个季度中，JNJ 有 6 个季度的营收达到或超过预期，而同期每股收益每次都超过预期。** 根据 Trade Alert 的数据，到周五，JNJ 期权意味着股价将有 2.4% 的双向波动；这高于该股在过去八个季度中在财报发布当天 1.9% 的平均波动率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".DJI","JNJ","BUZZ"],"gpt_icon":0},{"id":"2451644509","title":"强生  预计每股收益2.70美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2451644509","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451644509?lang=zh_cn&edition=full","pubTime":"2024-07-15 20:38","pubTimestamp":1721047098,"startTime":"0","endTime":"0","summary":"   * 强生公司   将于7月17日公布截至2024年6月30日的业绩报告，预计该公司的季度收入将出现下降。* LSEG 分析师对强生公司的平均预期为每股收益 2.70 美元。* 目前分析师对强生公司股票的平均评级为 \"买入\"，建议的细分为 13 个 \"强烈买入 \"或 \"买入\"，12 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对强生公司 12 个月目标价的中位数为 170.00 美元，高于其上次收盘价 149.88 美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2451643645","title":"近30年老兵回归强生中国，跨国药企为何在华密集换帅","url":"https://stock-news.laohu8.com/highlight/detail?id=2451643645","media":"澎湃新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451643645?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:53","pubTimestamp":1721040780,"startTime":"0","endTime":"0","summary":"今年4月，时任强生中国区主席、强生医疗科技中国区总裁宋为群提出辞呈，寻求外部发展机会。1985年，强生进入中国，目前在华设有10余家法律实体，5大供应链基地。今年1月，礼来中国宣布迎来新任总裁兼总经理Huzur Devletsah，这是礼来中国首位女性掌门人。2022年财报显示，礼来中国区收入14.53亿美元，同比下降13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151853429f4e7968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151853429f4e7968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0792757196.USD","LU1430594728.SGD","LU1244550494.USD","LU0466842654.USD","IE00BSNM7G36.USD","BK4550","BK4585","JNJ","LU0640476718.USD","LU2133065610.SGD","SG9999001440.SGD","BK4588","BK4592","LU1506573853.SGD","LU1066053197.SGD","LU1244550221.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU2468319806.SGD","LU0795875086.SGD","LU2347655156.SGD","LU0234572021.USD","LU1935042991.SGD","SG9999002224.SGD","LU1032466523.USD","LU1929549753.HKD","LU1023059063.AUD","LU1074936037.SGD","BK4568","BK4581","LU0345770993.USD","LU1162221912.USD","LU1267930813.SGD","LU1585245621.USD","LU0889566641.SGD","LU1032955483.USD","LU0912757837.SGD","LU2602419157.SGD","BK4504","LU1057294990.SGD","LU1244550577.SGD","LU1732800096.USD","LU0345770308.USD","IE00B19Z3581.USD","LU1221951046.USD","LU1221951129.SGD","LU1059921491.USD","LU1196500208.SGD","LU0795875169.SGD","BK4559"],"gpt_icon":0},{"id":"2451692039","title":"传奇生物被曝收百亿美元并购要约，业内预计强生将参与竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2451692039","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451692039?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:26","pubTimestamp":1721028404,"startTime":"0","endTime":"0","summary":"当日，传奇生物股价大涨超12%，市值逼近100亿美元。同日，界面新闻向金斯瑞生物和传奇生物询问该并购消息，双方均表示目前对此没有回应。传奇生物的首个高光时刻在其成立三年之后。另外，阿斯利康于2023年12月宣布收购国内CAR-T公司亘喜生物，加强其在血液瘤方面的布局。截至2024年第一季度末，传奇生物现金及其等价物、存款和短期投资为13亿美元。2023年，传奇生物亏损5.18亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515273895bedde4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515273895bedde4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1585245621.USD","LU1066051225.USD","LU1244550494.USD","LU1244550577.SGD","LU0234572021.USD","BK4559","LEGN","LU2347655156.SGD","LU2602419157.SGD","LU2133065610.SGD","BK4588","LU1032466523.USD","BK4550","LU1059921491.USD","BK4505","LU0345770993.USD","LU1244550221.USD","LU0912757837.SGD","LU0114720955.EUR","LU0795875169.SGD","LU1032955483.USD","LU1430594728.SGD","SG9999002224.SGD","BK4581","LU1221951129.SGD","LU1196500208.SGD","JNJ","LU1267930813.SGD","LU1506573853.SGD","BK4504","LU1162221912.USD","LU0795875086.SGD","LU0882574055.USD","LU1929549753.HKD","LU1935042991.SGD","LU1221951046.USD","BK4568","LU0889566641.SGD","LU0466842654.USD","IE00B19Z3581.USD","BK4007","LU1066053197.SGD","LU1074936037.SGD","IE00BSNM7G36.USD","SG9999001440.SGD","BK4139","BK4585","BK4592","LU0640476718.USD","LU0345770308.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com","stockEarnings":[{"period":"1week","weight":0.0321},{"period":"1month","weight":0.0621},{"period":"3month","weight":0.0458},{"period":"6month","weight":-0.0432},{"period":"1year","weight":-0.0813},{"period":"ytd","weight":-0.0131}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州成立。强生公司及其子公司在全球拥有大约152,700名员工，从事医疗保健领域的广泛产品的研发，生产和销售。强生公司是一家控股公司，在全球几乎所有国家/地区都有260多家运营公司开展业务。公司的主要重点是与人类健康和福祉相关的产品。强生执行委员会是主要的管理团队，负责公司的战略运营和资源分配。委员会负责监督和协调公司三个业务部门的活动：消费者，制药和医疗设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.000425},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005666},{"month":3,"riseRate":0.590909,"avgChangeRate":0.016904},{"month":4,"riseRate":0.644444,"avgChangeRate":0.034378},{"month":5,"riseRate":0.488889,"avgChangeRate":-0.026323},{"month":6,"riseRate":0.511111,"avgChangeRate":0.006092},{"month":7,"riseRate":0.6,"avgChangeRate":0.01205},{"month":8,"riseRate":0.5,"avgChangeRate":0.002512},{"month":9,"riseRate":0.5,"avgChangeRate":0.003139},{"month":10,"riseRate":0.704545,"avgChangeRate":0.022035},{"month":11,"riseRate":0.613636,"avgChangeRate":0.017008},{"month":12,"riseRate":0.659091,"avgChangeRate":0.014337}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}